Page last updated: 2024-12-08

3-(2-iodoacetamido)-2,2,5,5-tetramethyl-1-pyrrolidinyloxyl

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-(2-iodoacetamido)-2,2,5,5-tetramethyl-1-pyrrolidinyloxyl: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID161551
CHEBI ID187888
MeSH IDM0095066

Synonyms (21)

Synonym
3-(2-iodoacetamido)-proxyl, free radical
ipsl
3-(2-iodacetamid)-2,2,5,5-tetramethyl-1-pyrrolidinyloxy
4-(iodoacetamido)-1-oxyl-2,2,5,5-tetramethylpyrrolidine
27048-01-7
CHEBI:187888
3-(2-iodacetamido)-proxyl
proxyliodoacetamide
3-(2-iodoacetamido)proxyl
(iodoacetamido)proxyl
1-pyrrolidinyloxy, 3-((iodoacetyl)amino)-2,2,5,5-tetramethyl-
3-(2-iodoacetamido)-2,2,5,5-tetramethyl-1-pyrrolidinyloxyl
5-iasl
iodoacetamido-proxyl
FT-0613564
AKOS015898277
3-(2-iodoacetamido)-proxyl
3-(2-iodoacetamido)-2,2,5,5-tetramethyl-1-pyrolidinyloxy, free radical
DTXSID80949807
{3-[(1-hydroxy-2-iodoethylidene)amino]-2,2,5,5-tetramethylpyrrolidin-1-yl}oxidanyl
2-iodo-n-(1-$l^{1}
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
aminoxylsRadicals derived from hydroxylamines by removal of the hydrogen atom from the hydroxy group. The synonymous terms nitroxyl radicals and nitroxides erroneously suggest the presence of a nitro group.
pyrrolidinecarboxamide
organoiodine compoundAn organoiodine compound is a compound containing at least one carbon-iodine bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (16.67)18.7374
1990's5 (41.67)18.2507
2000's3 (25.00)29.6817
2010's2 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.97 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]